Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2022-07-22 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an analyst/institutional investor meeting. It references SEBI regulations and provides meeting details but does not contain any financial data, report content, or detailed presentation materials. The document is an announcement of a meeting schedule rather than a report or transcript. Given its nature and length (1543 characters), it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-07-22 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an analyst/institutional investor meeting. It references SEBI regulations related to disclosure requirements but does not contain any financial data, report, or detailed presentation. The document is an announcement of a meeting schedule rather than a report or transcript. Given its brief length (1543 characters) and content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2022-07-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of an analyst/institutional investor meeting, referencing SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It does not contain any financial data, report content, or detailed presentation materials. It is an announcement of a meeting schedule rather than a report or transcript. Given the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-22 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an analysts/investors call about the unaudited financial results for the quarter ended June 30, 2022. It provides a link to the audio recording of the call held on July 20, 2022. The document does not contain actual financial statements or detailed financial data, but rather is an announcement of the availability of the call recording. Therefore, it is not the earnings release itself, nor the interim report, but a communication related to the call. Given the content, the best fitting category is Call Transcript (CT), as it pertains to the analysts/investors call on quarterly results, even though it is an announcement of the recording rather than a transcript. However, since the document only provides a link to the audio recording and does not contain the transcript text, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call recording availability and does not contain the transcript or financial data itself.
2022-07-20 English
Please find below the link to the audio recording of the Analysts/Investors Call on the Unaudited Financial Results of the Company for the quarter ended June 30, 2022 held on Wednesday, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an analysts/investors call about the unaudited financial results for the quarter ended June 30, 2022. It provides a link to the audio recording of the call held on July 20, 2022. The document does not contain the transcript itself, financial statements, or detailed analysis, but rather is an announcement of the availability of the call recording. Given the content and length (1263 characters), this fits the category of a Call Transcript (CT) announcement or related communication. However, since it only provides a link to the audio recording and does not include the transcript text, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call recording availability, not the transcript itself or a financial report.
2022-07-20 English
The Board of Directors at its Meeting held on July 19, 2022 has, inter alia, approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2022. As per Regulation ....
Earnings Release Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of unaudited financial results for the quarter ended June 30, 2022. It mentions that the Board of Directors approved these results on July 19, 2022, and that the results were published in newspapers and made available on the company's website. The document includes an extract of the financial results with key figures for the quarter and references to the full detailed results being available elsewhere. The document is primarily an announcement of the unaudited quarterly financial results rather than the full detailed report itself. It is not a full interim or quarterly report containing comprehensive financial statements and analysis, but rather a notification and summary of the results. Therefore, according to the "Menu vs Meal" rule, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Q1 2023
2022-07-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.